Praxis Precision Medicines (PRAX) Return on Invested Capital (2020 - 2021)

Praxis Precision Medicines (PRAX) recorded quarterly Return on Invested Capital of 0.0% in Q3 2021, down 45.84% quarter-over-quarter from 0.0% in Q1 2021.

Praxis Precision Medicines (PRAX) Return on Invested Capital (2020 - 2021) Analysis & Trends

Praxis Precision Medicines' Return on Invested Capital history runs 2 years deep, the most recent figure standing at 0.0% for Q3 2021.

  • In Q3 2021, Return on Invested Capital changed N/A year-over-year to 0.0%; the TTM figure through Sep 2021 stood at 0.0% (changed N/A YoY), while the FY2020 annual figure was 0.01%, changed N/A from the prior year.
  • Return on Invested Capital was 0.0% for Q3 2021 at Praxis Precision Medicines, down from 0.0% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q1 2021 to a low of 0.01% in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.01%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -0.01%
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -0.01%
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.00%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Praxis Precision Medicines 200.22 Mn -586.65 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2021 0.00%
Mar 31, 2021 0.00%
Dec 31, 2020 -0.01%